Works matching IS 01615505 AND DT 2023 AND VI 64 AND IP 5


Results: 26
    1
    2
    3
    4

    What Is Theranostics?

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 669, doi. 10.2967/jnumed.123.265670
    By:
    • Weber, Wolfgang A.;
    • Barthel, Henryk;
    • Bengel, Frank;
    • Eiber, Matthias;
    • Herrmann, Ken;
    • Schäfers, Michael
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Amino Acid PET in Neurooncology.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 693, doi. 10.2967/jnumed.122.264859
    By:
    • Galldiks, Norbert;
    • Lohmann, Philipp;
    • Fink, Gereon R.;
    • Langen, Karl-Josef
    Publication type:
    Article
    11
    12
    13
    14

    Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 751, doi. 10.2967/jnumed.122.264752
    By:
    • Ertveldt, Thomas;
    • Krasniqi, Ahmet;
    • Ceuppens, Hannelore;
    • Puttemans, Janik;
    • Dekempeneer, Yana;
    • De Jonghe, Kevin;
    • de Mey, Wout;
    • Lecocq, Quentin;
    • De Vlaeminck, Yannick;
    • Awad, Robin Maximilian;
    • Goyvaerts, Cleo;
    • De Veirman, Kim;
    • Morgenstern, Alfred;
    • Bruchertseifer, Frank;
    • Keyaerts, Marleen;
    • Devoogdt, Nick;
    • D'Huyvetter, Matthias;
    • Breckpot, Karine
    Publication type:
    Article
    15
    16

    Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 711, doi. 10.2967/jnumed.122.264689
    By:
    • Hirmas, Nader;
    • Hamacher, Rainer;
    • Sraieb, Miriam;
    • Ingenwerth, Marc;
    • Kessler, Lukas;
    • Pabst, Kim M.;
    • Barbato, Francesco;
    • Lueckerath, Katharina;
    • Kasper, Stefan;
    • Nader, Michael;
    • Schildhaus, Hans-Ulrich;
    • Kesch, Claudia;
    • von Tresckow, Bastian;
    • Hanoun, Christine;
    • Hautzel, Hubertus;
    • Aigner, Clemens;
    • Glas, Martin;
    • Stuschke, Martin;
    • Kümmel, Sherko;
    • Harter, Philipp
    Publication type:
    Article
    17
    18
    19

    <sup>64</sup>Cu Treatment Planning and <sup>67</sup>Cu Therapy with Radiolabeled [<sup>64</sup>Cu/<sup>67</sup>Cu]MeCOSar-Octreotate in Subjects with Unresectable Multifocal Meningioma: Initial Results for Human Imaging, Safety, Biodistribution, and Radiation Dosimetry.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 704, doi. 10.2967/jnumed.122.264586
    By:
    • Bailey, Dale L.;
    • Willowson, Kathy P.;
    • Harris, Matthew;
    • Biggin, Colin;
    • Aslani, Alireza;
    • Lengkeek, Nigel A.;
    • Stoner, Jon;
    • Eslick, M. Enid;
    • Marquis, Harry;
    • Parker, Michelle;
    • Roach, Paul J.;
    • Schembri, Geoffrey P.
    Publication type:
    Article
    20
    21
    22
    23

    Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 724, doi. 10.2967/jnumed.122.264470
    By:
    • Lumish, Melissa A.;
    • Maron, Steven B.;
    • Paroder, Viktoriya;
    • Chou, Joanne F.;
    • Capanu, Marinela;
    • Philemond, Steven;
    • O'Donoghue, Joseph A.;
    • Schöder, Heiko;
    • Lewis, Jason S.;
    • Lyashchenko, Serge K.;
    • Pandit-Taskar, Neeta;
    • Janjigian, Yelena Y.
    Publication type:
    Article
    24
    25
    26